Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 25 or more amino acid residues in defined sequence
Patent
1993-03-15
1996-10-15
Warden, Jill
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
25 or more amino acid residues in defined sequence
530345, 530402, 530403, 530404, 530325, 530326, 530327, 530810, 4241841, 4241851, 4242041, 4242341, 4242651, 4242751, 4242781, 4242271, A61K 3800, A61K 3900, A61K 4500, C17K 500
Patent
active
055655483
ABSTRACT:
A hepatitis B vaccine containing a peptide with an amino acid chain of at least six consecutive amino acids within the pre-S gene coded region of the envelope of hepatitis B virus. The vaccine being free of an amino acid sequence corresponding to the naturally occurring envelope proteins of hepatitis B virus and a physiologically acceptable diluent. The peptide being free or linked to a carrier. The carrier being a conventional carrier or a novel carrier including a lipid vesicle stabilized by cross-linking and having covalently bonded active sites on the outer surface thereon. Such novel carrier being useful not only to link the novel peptide containing an amino acid chain with amino acids within the pre-S gene coded region of the surface antigen of hepatitis B virus, but can also be used to bind synthetic peptide analogues of other viral proteins, as well as bacterial, allergen and parasitic proteins of man and animals. The peptides of the invention can be utilized in diagnostics for the detection of antigens and antibodies.
REFERENCES:
patent: 4415491 (1983-11-01), Vyas
patent: 4428941 (1984-01-01), Galibert et al.
patent: 4599230 (1986-06-01), Milich et al.
patent: 4683136 (1987-04-01), Milich et al.
patent: 4816564 (1989-03-01), Ellis et al.
patent: 4847080 (1989-07-01), Neurath et al.
patent: 4935235 (1990-06-01), Rutler et al.
patent: 5204096 (1993-04-01), Neurath et al.
Neurath et al, J. Gen Virol, vol. 65, pp. 1009-1014, 1984.
Ono et al. "The complete nucleotide sequence of the . . . virus DNA; subtype adr and adw" Nucleic acids Research, vol. 11, No. 6, pp. 1747-1767, 1983.
Valenzuela et al, "Nucleotide sequence of the gene coding for the major protein of hepatitis B surface antigen" Nature, vol. 280, pp. 815-819, 1979.
Chemical Abstracts, vol. 100, No. 19, May 7, 1984, p. 139, Ref. No. 1511965c: Columbus, OH, US & JP-A-58 194 897 (Takeda Chem. Ind. Ltd.) Dec. 11, 1983.
Journal of Virology, vol., 46, No. 2, May 1983, pp. 626-628; Am. Soc. for Microbiology, US W. Stibbe et al.; "Structural relationship between . . . antigen".
Gastroenterology, vol. 85, No. 2, 1983, pp. 268-274; Am. Gastroenterological Asso., US A. Machida et al.: "A Hepatitis B surface antigen polypeptide (P31) albumins".
Proc. Natl. Aca. Sci. USA, vol. 78, No. 6, Jun. 1981, pp. 3824-3828; US, T. P. Hopp et al; "Prediction of protein antigenic determinants . . . sequences".
Experientia, vol. 38, No. 5, May 1982, pp. 629-630; Basel, CH P. K. Das et al.: "Liposomes as immunological carriers antibodies." p. 629, col. 1, lines 12-13, col. 2, lines 1-2.
Gastroenterology, vol. 86, 1984, pp. 910-918; Am. Gastroenterolocal Ass., US A. Machida et al.: "A polypeptide containing 55 amino acid virus . . . albumins".
Science, vol. 224, Apr. 27, 1984, pp. 392-395, A. R. Neurath et al.: "Location and chemical synthesis of a pre-S gene coded immunodominant . . . virus".
Immunodominant Epitope of Hepatitis B virus, vol. 101, p. 5405 y, (1984).
Chemical Abstracts; Machida et al. A polypeptide containing 55 amino acids residues coded by the pre-S region of . . . albumins, vol. 101, p. 34692 w, (1984).
Chemical Abstracts; Neurath et al. Location and chemical synthesis of a pre-s gene coded.
A. R. Mitchell, S. B. H. Kent, M. Engelhard and R. B. Merrifield, J. Org. Chem., 43, 2845-2852, (1978).
S. B. H. Kent, M. Riemen, Marie LeDoux, and R. B. Merrifield, Methods in Protein Sequence Analysis, pp. 205-213, Brookhaven Press, Brookhaven, N. Y., in press (1981).
S. B. H. Kent, Biomedical Polymers, eds, E. P. Goldberg and A. Nakajima (Academic Press, New York), 213-242, (1980).
W. Szmuness, Prog. Med. Virol., 24, 40 (1978).
R. P. Beasley, L.-Y. Hwang, C.-C. Ling, C.-S. Chien, Lancet, Nov., 21.
Krugman, Viral Hepatitis: Laboratory and Clinical Science, F. Deinhardt, J. Deinhardt, Eds., Marcel Dekker, Inc. New York-Basel, 1983, pp. 257-263.
B. S. Blumberg, Science, 197, 17, (1977).
P. Tiollais, P. Charnay, G. N. Vyas, Science, 213, 406, (1981).
Williams, Am. J. Med. Sci., 270, 165 (1975).
W. Szumuness, et al., N. Engl. J. Med., 307, 1481; (1982).
J. W.-K. Shih, J. L. Gerin, J. Immunol., 115,634 (1975).
J. W.-K. Shih, P. L. Tan, J. L. Gerin, J. Immunol., 120, 520 (1978).
S. Mishiro, M. Imai, K. Takahashi, A. Machida, T. Gotanda, Y. Miyakawa, M. Mayumi, J. Immunol., 124, 1589, (1980).
G. R. Dressman, R. Cahirez, M. Suarez, F. B. Hollinger, R. J. Courtney, J. L. Melnick, J. Virol., 16, 508, (1975).
N. Williams, Nature, 306, 427, (1983).
A. Machida, et al, Gastroenterology, 85, 268, (1983).
Nima, H. L., et al, "Generation of Protein-Reactive . . . Recognition", Proceedings of the National Academy of Sciences USA, 80, 4949-4953, (1983).
Kennedy, R. C., Dressman, et al., "Inhibition of A Common Human Anit-Hepatitis B. Surface . . . Peptide", Journal of Virology, 46, 653-655, (1983).
Dressman, G. R., Sanchez, et al., "Antibody To Hepatitis B. Surface . . . Peptides", Nature, 295, 158-160, (1982).
G. N. Vyas, K. R. Rao, A. B. Ibrahim, Science, 178, 1300, (1972).
G. R. Dressman, et al, J. Gen. Virol., 19, 129, (1973).
A. R. Neurath, N. Strick, J. Med. Virol., 6, 309, (1980).
A. R. Neurath, S. B. H. Kent, and N. Strick, Proc. Natl. Acad, Sci. USA 79, 7871 (1982).
F. Galibent, T. N. Che, E. Mandart, J. Virol., 41 51, (1982).
Oku, N. Scheere, J. F., and MacDonald, R. C., "Preparation of Giant Liposomes", Biochimica et Biophysica Acta, 692, 384-388, (1982).
Dancey, G. F., et al., "Effect of Liposomal Model Membrane on Immunogenicity", The Journal of Immunology, 120, 1109-1113, (1978).
Alkan, S. S., et al., "Antigen Recognition and The Immune Response: The Capacity of . . . Hapten", the Journal of Immunology, 107, 353-358, (1971).
Alkan, S. S., et al., "Antigen Recognition And The Immune Response . . . Antigen Molecules", The Journal of Experimental Medicine, 135, 1228-1246, (1972).
V. P. Torchilin, et al., "Comparative Studies On Covalent and . . . Liposomes", Biochemical and Biophysical Research Communications, vol. 85, No. 3, 1978, pp. 983-990.
V. K. Jansons and P. L. Mallett, "Targeted Liposomes: A Method For Preparation and Analysis", Analytical Biochemistry III, pp. 54-59, 1981.
F. J. Martin and D. Papahadjopoulos, "Irreversible Coupling of Immunoglobulin . . . Vesicles", The Journal of Biological Chemistry, vol. 257, No. 1, Jan. 10, 1982, pp. 286-288.
D. Gerlier, "Liposomes As A Tool To Study . . . Tumor Antigen", J. Immunol., 131, 485, (1983).
L. D. Leserman, "Targeting To Cells of Fluorescent Liposomes Covalently Coupled With Monoclonal Antibody Or Protein A", Nature, 288, 602, (1980).
M. Tomasi, "Conjugation of Specific Antibodies To Sendai Virus Particles: A New Tool For Targeting Of Fusogenic Vesicles, Federation of European Biological Letters, 143, 252, (1982).
P. N. Shek, "Immune Response Mediated By Liposome-Associated Protein Antigens", Immunology, 45, 349, (1982).
F. J. Martin, "Immunospecific Targeting of Liposomes To Cells. A Novel And Efficient Method for Covalent Attachmentof Fab' Fragments Via Disulfide Bonds", Biochemistry, 20, 4229, (1981).
M. R. Mansk, "Targeting Of Lipod Vesicles", Proc. Antl. Acad. Sci. 77, 4430, (1980).
Kent Stephen B. H.
Neurath Alexander R.
California Institute of Technology
Davenport A. M.
New York Blood Center Inc.
Warden Jill
LandOfFree
Pre-S gene coded peptide hepatitis B immunogens and synthetic li does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pre-S gene coded peptide hepatitis B immunogens and synthetic li, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pre-S gene coded peptide hepatitis B immunogens and synthetic li will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1247198